Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,148 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00117598 | Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)(OPTIMAL) | completed | Phase 3 | 169 | PfizerINDUSTRY | 18 | Mar 30, 2015 | clinicaltrials |
| NCT00254891 | Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer | terminated | Phase 3 | 828 | PfizerINDUSTRY | 26 | Mar 30, 2015 | clinicaltrials |
| NCT00254904 | Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC | terminated | Phase 3 | 839 | PfizerINDUSTRY | 24 | Mar 30, 2015 | clinicaltrials |
| NCT00457691 | Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 768 | PfizerINDUSTRY | 34 | Mar 30, 2015 | clinicaltrials |
| NCT01450449 | Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme | completed | Phase 3 | 115 | International Atomic Energy AgencyOTHER_GOV | 14 | Mar 24, 2015 | clinicaltrials |
| NCT00295763 | A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen. | completed | Phase 3 | 61 | Genzyme, a Sanofi CompanyINDUSTRY | 5 | Mar 18, 2015 | clinicaltrials |
| NCT00005866 | S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia | completed | Phase 3 | 240 | SWOG Cancer Research NetworkNETWORK | 2 | Mar 6, 2015 | clinicaltrials |
| NCT00065325 | The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer(EFECT) | completed | Phase 3 | 694 | AstraZenecaINDUSTRY | 15 | Feb 24, 2015 | clinicaltrials |
| NCT00556322 | A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 27 | Feb 23, 2015 | clinicaltrials |
| NCT00556712 | A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 889 | Hoffmann-La RocheINDUSTRY | 28 | Feb 11, 2015 | clinicaltrials |
| NCT01046383 | Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients | terminated | Phase 3 | 16 | Immunotec Inc.INDUSTRY | 1 | Jan 21, 2015 | clinicaltrials |
| NCT01254279 | Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen | completed | Phase 3 | 984 | SanofiINDUSTRY | 29 | Jan 21, 2015 | clinicaltrials |
| NCT00863746 | A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).(MISSION) | completed | Phase 3 | 703 | BayerINDUSTRY | 34 | Jan 19, 2015 | clinicaltrials |
| NCT00484939 | A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 280 | Hoffmann-La RocheINDUSTRY | 12 | Jan 8, 2015 | clinicaltrials |
| NCT00049543 | Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery | completed | Phase 3 | 503 | National Cancer Institute (NCI)NIH | 1 | Jan 1, 2015 | clinicaltrials |
| NCT00009906 | Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor | terminated | Phase 3 | 748 | National Cancer Institute (NCI)NIH | 3 | Dec 23, 2014 | clinicaltrials |
| NCT00306137 | Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer | terminated | Phase 3 | 104 | BayerINDUSTRY | 10 | Dec 9, 2014 | clinicaltrials |
| NCT01164046 | Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism(Longheva) | terminated | Phase 3 | 56 | University Medical Center GroningenOTHER | 5 | Dec 3, 2014 | clinicaltrials |
| NCT00003313 | Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer | completed | Phase 3 | 243 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 21, 2014 | clinicaltrials |
| NCT00412061 | Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor(RADIANT-2) | completed | Phase 3 | 429 | Novartis PharmaceuticalsINDUSTRY | 15 | Nov 21, 2014 | clinicaltrials |
| NCT01650805 | Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC) | terminated | Phase 3 | 307 | Ariad PharmaceuticalsINDUSTRY | 24 | Nov 17, 2014 | clinicaltrials |
| NCT00761280 | Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma(SAPPHIRE) | terminated | Phase 3 | 27 | Isarna Therapeutics GmbHINDUSTRY | 16 | Nov 14, 2014 | clinicaltrials |
| NCT01104584 | Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)(GEMMA 2) | completed | Phase 3 | 460 | BayerINDUSTRY | 9 | Nov 11, 2014 | clinicaltrials |
| NCT01166542 | Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers | completed | Phase 3 | 167 | Oncolytics BiotechINDUSTRY | 13 | Nov 5, 2014 | clinicaltrials |
| NCT00123487 | Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML | completed | Phase 3 | 638 | Bristol-Myers SquibbINDUSTRY | 32 | Nov 3, 2014 | clinicaltrials |
| NCT00324155 | Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma | completed | Phase 3 | 681 | Bristol-Myers SquibbINDUSTRY | 25 | Nov 3, 2014 | clinicaltrials |
| NCT00105443 | A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma(SHARP) | completed | Phase 3 | 602 | BayerINDUSTRY | 23 | Oct 31, 2014 | clinicaltrials |
| NCT00111007 | A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma | completed | Phase 3 | 270 | BayerINDUSTRY | 7 | Oct 31, 2014 | clinicaltrials |
| NCT00061984 | Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 3 | 455 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Oct 27, 2014 | clinicaltrials |
| NCT01121848 | Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer | completed | Phase 3 | 108 | SanofiINDUSTRY | 1 | Oct 27, 2014 | clinicaltrials |
| NCT01586611 | A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer(Panc001) | unknown | Phase 3 | 175 | AHS Cancer Control AlbertaOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT00720798 | An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies | completed | Phase 3 | 2,067 | Hoffmann-La RocheINDUSTRY | 34 | Sep 30, 2014 | clinicaltrials |
| NCT00059839 | Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma | completed | Phase 3 | 129 | Children's Oncology GroupNETWORK | 5 | Sep 22, 2014 | clinicaltrials |
| NCT01276639 | A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis | completed | Phase 3 | 901 | PfizerINDUSTRY | 11 | Sep 19, 2014 | clinicaltrials |
| NCT01309737 | A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis | completed | Phase 3 | 960 | PfizerINDUSTRY | 11 | Sep 19, 2014 | clinicaltrials |
| NCT01039298 | Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIAL | unknown | Phase 3 | 200 | University of British ColumbiaOTHER | 1 | Sep 10, 2014 | clinicaltrials |
| NCT00374322 | Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer | completed | Phase 3 | 3,166 | GlaxoSmithKlineINDUSTRY | 33 | Aug 18, 2014 | clinicaltrials |
| NCT00088166 | XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors | completed | Phase 3 | 200 | Celtic Pharma Development ServicesINDUSTRY | 2 | Aug 13, 2014 | clinicaltrials |
| NCT01214720 | A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer | completed | Phase 3 | 607 | Hoffmann-La RocheINDUSTRY | 21 | Aug 13, 2014 | clinicaltrials |
| NCT00002641 | Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | completed | Phase 3 | 350 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT00111020 | Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma | completed | Phase 3 | 2,567 | BayerINDUSTRY | 2 | Aug 6, 2014 | clinicaltrials |
| NCT00003070 | Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer | completed | Phase 3 | 13 | Children's Oncology GroupNETWORK | 3 | Aug 5, 2014 | clinicaltrials |
| NCT00003937 | Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma | completed | Phase 3 | 253 | Children's Oncology GroupNETWORK | 6 | Aug 5, 2014 | clinicaltrials |
| NCT00002875 | Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma | completed | Phase 3 | 421 | Children's Oncology GroupNETWORK | 5 | Aug 1, 2014 | clinicaltrials |
| NCT00003093 | Combination Chemotherapy in Treating Children With Neuroblastoma | completed | Phase 3 | 573 | Children's Oncology GroupNETWORK | 7 | Aug 1, 2014 | clinicaltrials |
| NCT00002610 | Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | completed | Phase 3 | 203 | Children's Oncology GroupNETWORK | 7 | Jul 25, 2014 | clinicaltrials |
| NCT00005578 | Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease | completed | Phase 3 | 219 | Children's Oncology GroupNETWORK | 3 | Jul 24, 2014 | clinicaltrials |
| NCT00424255 | Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery | completed | Phase 3 | 688 | GlaxoSmithKlineINDUSTRY | 22 | Jul 18, 2014 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials